A silent and pervasive threat is contaminating global water systems as pharmaceuticals, designed to be stable within the human body, prove to be equally resilient in the environment. Compounds like the antiepileptic drug carbamazepine are continuously released into waterways, bypassing conventional
The journey for a promising new drug from laboratory discovery to a patient's bedside can often span two decades, a timeline that represents a significant barrier to advancing public health and treating critical illnesses. This protracted and costly process is a widely acknowledged bottleneck in
The relentless progression of chronic cholestatic liver diseases, such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), presents a daunting challenge in modern medicine, where effective disease-modifying therapies remain frustratingly out of reach. For countless
Health authorities in Bangladesh have officially confirmed a local outbreak of the Zika virus, with ten laboratory-confirmed cases identified in and around the capital city of Dhaka between September and December 2024, providing conclusive evidence of domestic transmission and raising significant
The rapid integration of artificial intelligence into the pharmacy profession presents a profound and complex dilemma, forcing a critical evaluation of a technology that is simultaneously hailed as a revolutionary tool and flagged as a source of considerable, often poorly understood, risk. While
A new generation of pharmaceutical trade agreements is fundamentally reshaping the landscape of global healthcare, moving beyond abstract economic frameworks to become practical, patient-centric instruments designed to directly enhance the accessibility, affordability, and predictability of
